Novel Therapeutic Targets

Autoimmunity results from a break in self-tolerance involving humoral and/or cell-mediated immune mechanisms. One pathological consequence of a failure in central and/or peripheral tolerance is the generation of autoantibodies and subsequent formation of complement-fixing immune complexes that contribute to tissue damage. Prevailing pharmacological strategies for treating autoimmune diseases involve the use of broad-acting immunosuppressants that with long term use have associated toxicities. 

  • Drug Delivery Systems
  • Membrane Proteins/Antagonists & Inhibitors
  • Tumor Necrosis Factor-alpha/Metabolism

Related Conference of Novel Therapeutic Targets

April 04-05, 2024

38th International Conference on Immunology

Madrid, Spain
May 23-24, 2024

18th International Conference on European Immunology

Zurich, Switzerland

Novel Therapeutic Targets Conference Speakers

    Recommended Sessions

    Related Journals

    Are you interested in